The team at Oxford University behind the landmark RECOVERY trial of COVID-19 therapies now has monkeypox in its sights, with a study that will see if Siga Technologies' smallpox drug Tpoxx can be used ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results